v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 16,897,563 $ 24,907,963
Accounts receivable, net 448,815 2,291,533
Other receivables   526,070
Prepaid expenses and other current assets 502,912 495,178
Total Current Assets 17,849,290 28,220,744
Intangible assets, net   2,946,610
Goodwill   463,000
Property and equipment, net   44,756
Deferred offering costs 10,000 10,000
Total Assets 17,859,290 31,685,110
Current Liabilities:    
Accounts payable - suppliers 727,432 1,844,544
Accounts payable - trade 369,040 659,362
Accrued expenses and other current liabilities 716,484 2,493,287
Deferred revenue 767,833 395,914
Notes payable 1,539 151,336
Total Current Liabilities 2,582,328 5,544,443
Contingent consideration   613,000
Notes payable, non-current portion 77,361 77,407
Total Liabilities 2,659,689 6,234,850
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,402,500 and 14,253,948 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 144 143
Additional paid-in capital 52,891,794 52,030,907
Accumulated deficit (37,692,337) (26,580,790)
Total Stockholders' Equity 15,199,601 25,450,260
Total Liabilities and Stockholders' Equity $ 17,859,290 $ 31,685,110

Source